Search - tctmd.com

Displaying 781 - 800 of 2956

Sort: Relevancy | Date

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Anthony H. Gershlick

October 31, 2017

Presentation TCT 2017

Long-term Outcomes in the Real World: Effect of Socioeconomic Status, Healthcare Access, Compliance, and More

Presenter: Alice K. Jacobs, Spencer B. King III, A.J. Conrad C. Smith

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

Presenter: Antonio Colombo, David E. Kandzari, Duk-Woo Park

October 31, 2017

Presentation TCT 2017

STS, Euroscore, and the Need for a Frailty Index for CHIP Cases

Presenter: Farouc Jaffer, Ajay J. Kirtane, Adam C. Salisbury

October 31, 2017

Presentation TCT 2017

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Mathew Williams

October 31, 2017

Presentation TCT 2017

ACURATE Neo TAVR Technology Review and Clinical Program Updates

Presenter: Thomas Walther

October 31, 2017

Presentation TCT 2017

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

Presenter: Stefan K. James, Ran Kornowski, Jacob Lønborg, MD

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

Sex and Racial Disparities in TAVR

Presenter: Alice K. Jacobs, Spencer B. King III, David R. Holmes Jr.

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE I: DELTA-2

Presenter: Antonio Colombo, David E. Kandzari, Alaide Chieffo

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Presenter: Vladimir Dzavik, Navin K. Kapur, Robb Kociol

October 31, 2017

Presentation TCT 2017

Tools for Training: Mitigating Procedural Risk and Picking the Right Cases As a New CHIP Operator

Presenter: Farouc Jaffer, Ajay J. Kirtane, Raja Hatem

October 31, 2017

Presentation TCT 2017

Case #5: Stent Failure After Multiple Interventions

Presenter: João AB Brum Silveira, Marcelo Jose de Carvalho Cantarelli, Ricardo Santos

October 31, 2017

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

Presenter: Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Nicolo Piazza

October 31, 2017

Presentation TCT 2017

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

Presenter: Antonio Colombo, David E. Kandzari, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Presenter: Vladimir Dzavik, Navin K. Kapur, Mark B. Anderson

October 31, 2017

Presentation TCT 2017

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Vinayak Bapat

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Advertisement

Multivessel PCI Debate: Based on What We Know Today - Immediate Multivessel PCI Is the Preferred Strategy!

Long-term Outcomes in the Real World: Effect of Socioeconomic Status, Healthcare Access, Compliance, and More

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

STS, Euroscore, and the Need for a Frailty Index for CHIP Cases

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

ACURATE Neo TAVR Technology Review and Clinical Program Updates

When, If Ever, Should Stent Implantation Be Deferred in STEMI?

New Targets: Heart Failure With Preserved Ejection Fraction

Sex and Racial Disparities in TAVR

Exploring Diversity and Generalizability of EXCEL/NOBLE I: DELTA-2

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Tools for Training: Mitigating Procedural Risk and Picking the Right Cases As a New CHIP Operator

Case #5: Stent Failure After Multiple Interventions

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

LOTUS Procedural Pearls (Including How NOT to Need a New Pacemaker)

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content